🇺🇸 FDA

Intelligence Platform

Patents

Browse 86 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8366662

Drug releasing coatings for medical devices

Lutonix, Inc. · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8366660

Drug releasing coatings for medical devices

Lutonix, Inc. · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8329182

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293707

Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH

Syntonix Pharmaceuticals, Inc. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273351

Fc receptor binding proteins

Syntonix Pharmaceuticals, Inc. · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8244344

Drug releasing coatings for medical devices

Lutonix, Inc. · Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8241249

Drug releasing coatings for medical devices

Lutonix, Inc. · Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101186

Peptides that block the binding of IgG to FcRn

Syntonix Pharmaceuticals, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7862820

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820162

Methods for chemically synthesizing immunoglobulin chimeric proteins

Syntonix Pharmaceuticals, Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601516

Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment o

Syntonix Pharmaceuticals, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7404956

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7381408

Methods for chemically synthesizing immunoglobulin chimeric proteins

Syntonix Pharmaceuticals, Inc. · Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348004

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. · Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted